| Drug Name |
Sulfadiazine |
| Drug ID |
BADD_D02090 |
| Description |
One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. |
| Indications and Usage |
For the treatment of rheumatic fever and meningococcal meningitis |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J01EC02 |
| DrugBank ID |
DB00359
|
| KEGG ID |
D00587
|
| MeSH ID |
D013411
|
| PubChem ID |
5215
|
| TTD Drug ID |
D05LKP
|
| NDC Product Code |
38779-0550; 63422-703; 42806-757; 71236-0003; 76003-1055; 49452-7460; 0185-0757 |
| Synonyms |
Sulfadiazine | Sulphadiazine | Zinc Sulfadiazine | Sulfadiazine, Zinc | Sulfazin | Sulfazine |
